FDA Inspection
Nova Biologicals, IncNova Biologicals, Inc – FDA Inspection, Apr 6, 2026
Record Details
This FDA Inspection record concerns Nova Biologicals, Inc, with an inspection on April 6, 2026, issued by the Dallas District Office, covering human drugs.
- Office
- Dallas District Office
- Person
View Company Profile
ID · dfafca99-d183-4124-bbec-994243438002
Inspection Facts
- Inspection number
- 1312510
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nova Biologicals, Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 2, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nova Biologicals, Inc
- FDA Inspection 1042861 - 2018-02-23
- FDA Inspection 618033 - 2009-10-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.